Korro Bio and Frequency Therapeutics Announce Merger Agreement

Merger to create a Nasdaq-listed genetic medicines company focused on advancing Korro Bio’s wholly owned portfolio of RNA editing programs Lead prog...

July 17, 2023 | Monday | News
Lilly Acquires Versanis to Enhance Cardiometabolic Disease Care

Versanis' lead asset is bimagrumab, a monoclonal antibody that binds activin type II A and B receptors to block activin and myostatin signaling. Bimagrumab...

July 17, 2023 | Monday | News
Biosynth Expands Capabilities with Acquisition of celares

Expansion of capabilities provides customised bioconjugation solutions for Pharma and IVD industries. Biosynth, a supplier of critical raw materials to th...

July 12, 2023 | Wednesday | News
Thermo Fisher Scientific to Acquire CorEvitas

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced it has entered into a definit...

July 07, 2023 | Friday | News
ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software

Expands ResMed’s sleep management software solution, will help sleep labs and physicians more efficiently guide patients into and through diagnosis...

July 06, 2023 | Thursday | News
Syngene to acquire multi-modal facility from Stelis Biopharma Ltd

Syngene (or the “Company”) today announced the acquisition of Unit 3 biologics manufacturing facility in Bangalore, India, from Stelis Biopharm...

July 05, 2023 | Wednesday | News
Bausch + Lomb Will Acquire XIIDRA®

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced it h...

July 03, 2023 | Monday | News
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics

Merger approved with large majority by the shareholders of both companies New governance structure implemented Ambition to create a global leader in ex...

June 27, 2023 | Tuesday | News
Coherus to Acquire Surface Oncology

– Stock for stock transaction valued at up to $65 million, an approximate three-fold premium over Surface’s anticipated net cash of $20 to $25 ...

June 19, 2023 | Monday | News
Merck Completes Acquisition of Prometheus Biosciences, Inc.

Acquisition delivers industry-leading research capability, and strengthens pipeline with a novel candidate for ulcerative colitis, Crohn’s disease an...

June 17, 2023 | Saturday | News
RK Pharma Completes Acquisition of VGYAAN Pharmaceuticals

“The acquisition of VGYAAN Pharmaceuticals aligns strongly with our growth strategy that will deliver substantial value for our company, customers, a...

June 16, 2023 | Friday | News
PHC Holdings Acquires SciMed (Asia), Expanding Support for Researchers in Asia-Pacific

SciMed offers life science products and services, including ultra-low temperature freezers and CO2 incubators, in Southeast Asia, India, and Oceania. Since...

June 15, 2023 | Thursday | News
BurstIQ Acquires Business Intelligence Platform from Olive AI

BurstIQ, a trusted leader in data-driven healthcare solutions, proudly announces the acquisition of Olive AI's business intelligence solution. This...

June 14, 2023 | Wednesday | News
Labcorp Announces Information in Connection with its Spin-off of Fortrea

The record date will be 5 p.m. Burlington, North Carolina time on Tuesday, June 20, 2023, and The distribution date will be 11:59 p.m. Burlington, North...

June 12, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close